NAAG Urges OfferUp to Prevent the Sales of Fraudulent Vaccine Cards

The false and deceptive marketing and sales of fake COVID vaccine cards threatens the health of our communities, slows progress in getting our residents protected from the virus, and are a violation of the laws of many states.

Read More →

NAAG Works to Prevent the Online Sale of Fraudulent COVID Vaccination Cards

The false and deceptive marketing and sales of fake COVID vaccine cards threaten the health of our communities, slow progress in getting our residents protected from the virus, and are a violation of the laws of many states.

Read More →

NAAG Sends Letter to USDOJ Condemning January 6 Violence at U.S. Capitol

We all just witnessed a very dark day in America. The events of January 6 represent a direct, physical challenge to the rule of law and our democratic republic itself. Together, we will continue to do our part to repair the damage done to institutions and build a more perfect union. As Americans, and those charged with enforcing the law, we must come together to condemn lawless violence, making clear that such actions will not be allowed to go unchecked.

Read More →

NAAG Asks FDA for Progress Update Under the SUPPORT Act

We have witnessed first-hand the devastation that the opioid epidemic has wrought on states in terms of lives lost and the costs it has imposed on our healthcare system and the broader economy.

Read More →

Settlement Agreement Between Plaintiff States and UBS (Dec. 21, 2018)

Forty plaintiff states reached a $68 million settlement with UBS for fraudulent conduct involving interest rate manipulation that had a significant impact on consumers and financial markets around the world. UBS’ fraudulent conduct involved the manipulation of LIBOR (the London Interbank Offered Rate). LIBOR is a benchmark interest rate that affects financial instruments worth trillions…

Read More →

FTC et al. v. Vyera Pharmaceuticals, No. 1:20-cv-00706 (S.D.N.Y. Apr. 19, 2020)

The FTC, New York and six other states filed suit against Vyera Pharmaceuticals, its parent company, Phoenixus and its former officers, Kevin Mulleady and Martin Shkreli, alleging anticompetivie conduct in connection with Daraprim, the only FDA approved drug for the treatment of the life-threatening parasitic disease toxoplasmosis.  The suit alleges that Vyera purchases the unpatented…

Read More →

NAAG Supports Daniel’s Law

The Daniel Anderl Judicial Security and Privacy Act honors the memory of the son of Judge Esther Salas of the U.S. District Court for the District of New Jersey. Daniel was tragically killed on July 19, 2020, when an armed assailant—a deranged attorney who had appeared in a case before Judge Salas—appeared at her home and opened fire. Daniel was only 20. Judge Salas’s husband was also shot in the attack. 

Read More →

NAAG Urges Congress to Extend CARES Act Spending Deadline

With COVID-19 cases rising daily in much of the country and many states still under a health emergency declaration, we urge Congress to amend the CRF program to allow state and local governments to spend the funding at least until December 31, 2021.

Read More →

Attorneys General Urge Senate to Pass Law to Fight Shell Companies

As our States’ chief legal officers, we are concerned about the use of American financial institutions for money laundering by terrorist groups and other criminal enterprises.

Read More →

Attorneys General Ask Apple and Google to Ensure All Contact Tracing Apps Serve a Public Health Purpose

Digital contact tracing may provide a valuable tool to understand the spread of COVID-19 and assist the public health response to the pandemic. However, such technology also poses a risk to consumers’ personally identifiable information, including sensitive health information, that could continue long after the present public health emergency ends.

Read More →